TIDMODX
RNS Number : 6537F
Omega Diagnostics Group PLC
08 November 2022
The information contained within this announcement is deemed by
the Company to constitute inside information as stipulated under
the Market Abuse Regulation (EU) No. 596/2014. Upon the publication
of this announcement via the Regulatory Information Service, this
inside information is now considered to be in the public
domain.
8 November 2022
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Establishment and initial operation of tax-advantaged
all-employee share incentive plan
1. Establishment of the Omega Diagnostics Group PLC Share Incentive Plan
Omega (AIM: ODX), the specialist medical diagnostics company
focused on promoting a personalised and functional approach to
health and nutrition, announces the establishment and launch of a
new HMRC tax-advantaged share scheme, namely the Omega Diagnostics
Group PLC Share Incentive Plan (the "SIP" or the "Plan").
The SIP, which was entered into in late September, has been
adopted to support the principles of wider share ownership amongst
all the Company's employees. It allows eligible individuals
(including Omega's executive directors) to be invited to purchase
ordinary shares of 4 pence each in the capital of the Company
("Ordinary Shares") via the SIP trustee using salary deductions
(which, in aggregate, cannot exceed GBP1,800 per employee over any
one tax year). The Ordinary Shares acquired in this manner are
referred to as "Partnership Shares" and, for each Partnership Share
purchased, participants are awarded one further free Ordinary
Share, known as a "Matching Share."
Matching Shares must normally be held in the SIP for a minimum
holding period of 3 years and will usually be forfeited if, during
that period, the participant in question ceases employment or
withdraws their corresponding Partnership Shares from the Plan.
2. Initial purchase of Partnership Shares and award of Matching Shares
On 7 November 2022, the Company received notification from Link
Market Services Trustees Limited, the trustee of the SIP, that, on
7 November 2022, it purchased an aggregate of 130,908 Partnership
Shares in the market at a price of 2.75p per share on behalf of
those Directors set out in the table below. At the same time, these
individuals were also awarded (for no consideration) their
corresponding Matching Shares.
Director Board Number of Partnership Number of Total beneficial holding
Position Shares acquired Matching Shares of Ordinary Shares following
under the SIP acquired under these acquisitions
on 7 November the SIP on
2022 7 November
2022
Number of Approximate
Ordinary % of Company's
Shares issued share
capital
------------
Jag Grewal CEO 65,454 65,454 1,025,834 0.43%
----------- ---------------------- ----------------- ------------ ------------------
Chris Lea CFO 65,454 65,454 1,030,908 0.43%
----------- ---------------------- ----------------- ------------ ------------------
The salary deductions used by each of the above-noted Directors
to acquire their Partnership Shares amounted to GBP1,800, being the
maximum level of contribution that can be made to the SIP by an
individual in any single tax year.
Contacts:
Omega Diagnostics Group PLC www.omegadx.com
Jag Grewal, Chief Executive Officer via Walbrook PR
Chris Lea, Chief Financial Officer
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Edward Whiley/George Dollemore (Corporate
Finance)
Alice Lane/Charlotte Sutcliffe
(ECM)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Applegarth Mob: 07584 391 303
Sam Allen Mob: 07502 558 258
About Omega Diagnostics Group PLC
Omega (AIM: ODX) is a specialist medical diagnostics company
focused on promoting a personalised and functional approach to
health and nutrition .
www.omegadx.com
Notification of transactions of persons discharging managerial
responsibilities and persons closely associated with them
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Jag Grewal
--------------------- -------------------------------------------------------
Reason for the notification
2
------------------------------------------------------------------------------
a) Position/status Chief Executive Officer
--------------------- -------------------------------------------------------
b) Initial notification Initial Notification
/Amendment
--------------------- -------------------------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------
a) Name Omega Diagnostics Group PLC
--------------------- -------------------------------------------------------
b) LEI 2138007U9P4BTZTYIR92
--------------------- -------------------------------------------------------
Details of the transaction(s): section to be repeated for
4 (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
------------------------------------------------------------------------------
a) Description Ordinary Shares of 4 pence each ("Ordinary Shares")
of the financial
instrument,
type of instrument
ISIN: GB00B1VCP282
Identification
code
--------------------- -------------------------------------------------------
b) Nature of Ordinary Shares purchased under the "Partnership
the transaction Share" element of the Company's all-employee
Share Incentive Plan.
--------------------- -------------------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
2.75p 65,454
--------- ----------
--------------------- -------------------------------------------------------
d) Aggregated Not applicable
information
-Aggregated
volume
- Price
--------------------- -------------------------------------------------------
e) Date of the 2022-11-7
transaction
--------------------- -------------------------------------------------------
f) Place of the London Stock Exchange
transaction
--------------------- -------------------------------------------------------
Details of the transaction(s): section to be repeated for
4 (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
------------------------------------------------------------------------------
a) Description Ordinary Shares of 4 pence each ("Ordinary Shares")
of the financial
instrument,
type of instrument
ISIN: GB00B1VCP282
Identification
code
--------------------- -------------------------------------------------------
b) Nature of Ordinary Shares awarded under the "Matching Share"
the transaction element of the Company's all-employee Share Incentive
Plan.
--------------------- -------------------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
Nil 65,454
---------- ----------
--------------------- -------------------------------------------------------
d) Aggregated Not applicable
information
-Aggregated
volume
- Price
--------------------- -------------------------------------------------------
e) Date of the 2022-11-7
transaction
--------------------- -------------------------------------------------------
f) Place of the London Stock Exchange
transaction
--------------------- -------------------------------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Chris Lea
--------------------- -------------------------------------------------------
Reason for the notification
2
------------------------------------------------------------------------------
a) Position/status Chief Financial Officer
--------------------- -------------------------------------------------------
b) Initial notification Initial Notification
/Amendment
--------------------- -------------------------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------
a) Name Omega Diagnostics Group PLC
--------------------- -------------------------------------------------------
b) LEI 2138007U9P4BTZTYIR92
--------------------- -------------------------------------------------------
Details of the transaction(s): section to be repeated for
4 (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
------------------------------------------------------------------------------
a) Description Ordinary Shares of 4 pence each ("Ordinary Shares")
of the financial
instrument,
type of instrument
ISIN: GB00B1VCP282
Identification
code
--------------------- -------------------------------------------------------
b) Nature of Ordinary Shares purchased under the "Partnership
the transaction Share" element of the Company's all-employee
Share Incentive Plan.
--------------------- -------------------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
2.75p 65,454
--------- ----------
--------------------- -------------------------------------------------------
d) Aggregated Not applicable
information
-Aggregated
volume
- Price
--------------------- -------------------------------------------------------
e) Date of the 2022-11-7
transaction
--------------------- -------------------------------------------------------
f) Place of the London Stock Exchange
transaction
--------------------- -------------------------------------------------------
Details of the transaction(s): section to be repeated for
4 (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
------------------------------------------------------------------------------
a) Description Ordinary Shares of 4 pence each ("Ordinary Shares")
of the financial
instrument,
type of instrument
ISIN: GB00B1VCP282
Identification
code
--------------------- -------------------------------------------------------
b) Nature of Ordinary Shares awarded under the "Matching Share"
the transaction element of the Company's all-employee Share Incentive
Plan.
--------------------- -------------------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
Nil 65,454
---------- ----------
--------------------- -------------------------------------------------------
d) Aggregated Not applicable
information
-Aggregated
volume
- Price
--------------------- -------------------------------------------------------
e) Date of the 2022-11-7
transaction
--------------------- -------------------------------------------------------
f) Place of the London Stock Exchange
transaction
--------------------- -------------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFZMGMNRKGZZG
(END) Dow Jones Newswires
November 08, 2022 04:04 ET (09:04 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Apr 2023 to Apr 2024
